Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Asvin Ganapathi

Thoracic Surgery (Cardiothoracic Vascular Surgery) Thousand Oaks, CA Medical Doctor

NPI 1013234061 CMS profile 648564

227 W Janss Rd Ste 340, Ste 340, Thousand Oaks, CA 91360

Open in the dashboard

General payments

$9,834

97 records reported · program years 2019–2025

Research payments

$436

Paid to them · 5 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$22,446 paid to institutions, not to them · program years 2020–2022

Through program year 2025, Asvin Ganapathi of Thousand Oaks, CA is reported in the CMS Open Payments database as having received $9,834 across 97 general payments and $436 in research payments paid to them. Separately, studies naming them as principal investigator received $22,446 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 67th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,564 35
2024 General $541 12
2023 General $259 7
2022 General $221 5
2021 General $166 4
2020 General $5,610 20
2019 General $1,472 14
2019 Research $436 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Asvin Ganapathi
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Asvin Ganapathi were reported at $1,564. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Asvin Ganapathi Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $1,472 $886 $178–$3,167 $163
2020 $5,610 $341 $108–$1,605 $114
2021 $166 $453 $125–$1,886 $132
2022 $221 $695 $180–$2,566 $149
2023 $259 $745 $205–$2,662 $160
2024 $541 $799 $214–$2,967 $164
2025 $1,564 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic Vascular, Inc. $4,310 32 payments
  2. Allergan Inc. $2,763 1 payment
  3. Abiomed $872 10 payments
  4. Medtronic, Inc. $866 33 payments
  5. Atricure, Inc. $258 4 payments
  6. Abbott Laboratories $249 3 payments
  7. Boston Scientific Corporation $151 2 payments
  8. Edwards Lifesciences Corporation $111 1 payment
  9. CryoLife, Inc. $74 3 payments
  10. Ethicon US, LLC $39 1 payment
  11. Other $142 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,177 86 payments
  2. Travel and Lodging $2,895 10 payments
  3. Consulting Fee $2,763 1 payment
Products named General payments · program years 2019–2025
  1. BOTOX $2,763 1 payment
  2. Tri-Ad $1,514 9 payments
  3. CoreValve Evolut $1,462 13 payments
  4. HeartWare HVAD $1,161 9 payments
  5. COREVALVE EVOLUT R $378 14 payments
  6. Impella $218 2 payments
  7. ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) $217 2 payments
  8. SYNERGY ABLATION SYSTEM $197 2 payments
  9. ATRICLIP LAA EXCLUSION SYSTEM $193 1 payment
  10. Mosaic $172 1 payment
  11. Other $1,341 43 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. TransMedics, Inc. $436 5 payments

Billing to Medicare

Part B · data year 2024 · 47 billing codes

Paid by Medicare

$91,004

Medicare's payments for the services billed

Medicare patients

118

Average age 72

Services billed

264

44 women, 74 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 49%
Arthritis 46%
Diabetes 44%
Atrial fibrillation 41%
Chronic kidney disease 40%
COPD 40%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

102 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record